CLEFT PALATE IN HIV-EXPOSED NEWBORNS OF MOTHERS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY. - Wikidata - awgldk - TriplyDB

CLEFT PALATE IN HIV-EXPOSED NEWBORNS OF MOTHERS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY.

CLEFT PALATE IN HIV-EXPOSED NEWBORNS OF MOTHERS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY.

http://www.wikidata.org/entity/Q35038144

about

Clinical relevance of breast and gastric cancer-associated polymorphisms as potential susceptibility markers for oral clefts in the Brazilian population Determinants of orofacial clefting II: Effects of 5-Aza-2'-deoxycytidine on gene methylation during development of the first branchial arch.

P2860

Q36334815-AE527AAA-D961-4458-A5B5-BC1A4EE314AA Q39126176-F8515200-E7E4-4303-B0D3-3FADD279FA2A

P2860

CLEFT PALATE IN HIV-EXPOSED NEWBORNS OF MOTHERS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY.

http://www.wikidata.org/entity/Q35038144

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

CLEFT PALATE IN HIV-EXPOSED NEWBORNS OF MOTHERS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY.

@ast

CLEFT PALATE IN HIV-EXPOSED NEWBORNS OF MOTHERS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY.

@en

type

label

CLEFT PALATE IN HIV-EXPOSED NEWBORNS OF MOTHERS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY.

@ast

CLEFT PALATE IN HIV-EXPOSED NEWBORNS OF MOTHERS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY.

@en

prefLabel

CLEFT PALATE IN HIV-EXPOSED NEWBORNS OF MOTHERS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY.

@ast

CLEFT PALATE IN HIV-EXPOSED NEWBORNS OF MOTHERS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY.

@en

P1433

Q35038144-46B53CE0-8EDE-4B54-8AEF-9DF3C155A656

P1476

Q35038144-ADB88FED-B997-4A35-B26E-546117847BE3

P2093

Q35038144-1B6D703E-C391-4069-A3C7-B741FEE3C889

Q35038144-66515C46-C57E-4D1B-BF23-97C5434C3846

Q35038144-6A1FC9BD-94FF-4164-B1A1-D1CAFE86E917

Q35038144-6EC95C2B-4191-4D8F-8B0A-D1B42878FE11

Q35038144-7B9514CC-F3C7-4E47-BF4F-55AE4968E832

Q35038144-92F5D735-87BC-473A-BE2E-6CE906BD76EF

Q35038144-95E19D1C-9116-4621-AD63-CF7A2FB884B1

Q35038144-B3A7C944-8FFD-446F-95C5-D9D3BA3EE838

Q35038144-B8BA000F-9891-43DE-B77D-55D09AA3F3FF

Q35038144-E7FE61A1-7B3B-4B81-AFA4-37600920096E

P2860

Q35038144-0B073C34-47B3-4E70-A8BC-0F9584D33AB0

Q35038144-1CFFB9B5-7BC3-4BCA-AADD-C90FFE5DA74F

Q35038144-2B4E5160-05C5-4304-B864-7EB2A005E256

Q35038144-334AD959-951E-4706-8172-1D4226B5D3CE

Q35038144-35B9ABE3-1EE7-4F7B-8B88-AEF6A48019EC

Q35038144-42D2CD74-10EA-4A47-8235-B125E1012023

Q35038144-49809874-4F95-4D63-89AA-B4AE8EEE3D6E

Q35038144-4ED0C003-15A5-46D7-B4BA-D74784931107

Q35038144-523A5932-0C7F-4096-AE36-3ED6D91486B3

Q35038144-552107E9-8417-4467-92DD-56A562F58092

P304

Q35038144-53F977D5-AD0A-4505-8983-52C05D20036C

P31

Q35038144-523A120D-1C3E-41CE-98E7-0AE7F1078ECB

P356

Q35038144-20E9E3ED-6FE9-435A-90CE-B29A65B930E6

P433

Q35038144-D3DF6A61-A21E-41B7-BBFC-2D5871979E4A

P478

Q35038144-B99D297D-AFFD-43E8-8494-B7E81435D6BB

P577

Q35038144-9EE41CA9-B0AD-4C9B-B0FA-9010DC5E8059

P698

Q35038144-23D67EA4-B920-4A0A-BACB-87D2AF0D4D83

P921

Q35038144-B1B54D56-6508-4430-8D9F-FD5D18A30F1C

P932

Q35038144-05D25ACC-E4FA-4548-854A-11CEA1ABD090

P356

P1433

P1476

CLEFT PALATE IN HIV-EXPOSED NEWBORNS OF MOTHERS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY.

@en

P2093

Ayotunde James

http://www.w3.org/2001/XMLSchema#string

Babafemi

http://www.w3.org/2001/XMLSchema#string

Babatunde Oluwatosin

http://www.w3.org/2001/XMLSchema#string

David Olufemi

http://www.w3.org/2001/XMLSchema#string

Georgina Njideka

http://www.w3.org/2001/XMLSchema#string

Isaac Folorunso

http://www.w3.org/2001/XMLSchema#string

Olusegun Olusina

http://www.w3.org/2001/XMLSchema#string

Onyekwere George Benjamin

http://www.w3.org/2001/XMLSchema#string

Phylis

http://www.w3.org/2001/XMLSchema#string

Robert Leo

http://www.w3.org/2001/XMLSchema#string

P2860

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection

Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach

Is first trimester exposure to the combination of antiretroviral therapy and folate antagonists a risk factor for congenital abnormalities?

Disruption of Fgf10/Fgfr2b-coordinated epithelial-mesenchymal interactions causes cleft palate

Oral clefts and vitamin supplementation.

Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.

Maternal antiretroviral use during pregnancy and infant congenital anomalies: the NISDI perinatal study.

Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C.

Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis.

Efavirenz use during pregnancy and for women of child-bearing potential

P304

102-106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ORS.12117

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25653715

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

4313880

http://www.w3.org/2001/XMLSchema#string